VNDA Vanda Pharmaceuticals
- 4.620
- +0.140+3.13%
- 4.520
- -0.100-2.17%
Vanda Pharmaceuticals News
Express News | Shareholder Capital LLC : Calls Vanda Pharmaceuticals' Board to Reconsider Future Pak's Offer
Express News | Shareholder Capital LLC : Believes Vanda's Board Must Explore Strategic Alternatives
Express News | Shareholder Capital LLC : Delivers Letter to Independent Members of Board of Vanda Pharmaceuticals
Vanda Pharmaceuticals (VNDA) Stock Sinks As Market Gains: What You Should Know
Vanda (VNDA) to Report Q1 Earnings: What's in the Cards?
Vanda Pharmaceuticals Reacts to U.S. Supreme Court's Denial of Its Petition in HETLIOZ® ANDA Litigation
Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the Supreme Court denied Vanda's petition for a writ of certiorari in its...
Express News | Vanda Pharmaceuticals Shares Are Trading Higher After the US Supreme Court Reportedly Declined to Hear the Company's Case Regarding the Invalidation of Patents for Hetlioz
Express News | Vanda Pharmaceuticals Shares Down 6.1% After U.S. Supreme Court Rejects Co's Case Over Sleep-Drug Patents
US Supreme Court Reportedly Declines to Hear Vanda Patent Case
U.S. Supreme Court Rejects Vanda Pharmaceuticals Case Over Sleep-drug Patents
Vanda Under Pressure From Hedge Fund to Discuss Future Pak Takeover Offer
Express News | Butler Hall Capital LLC : Vanda Pharmaceuticals Board Should Form Independent Special Committee to Engage With Future Pak & Run Full Sales Process
Express News | Butler Hall Capital LLC Has Issued an Open Letter to Vnda’s Board of Directors Urging the Company to Run a Full Sales Process to Maximize Shareholder Value
Investors Heavily Search Vanda Pharmaceuticals Inc. (VNDA): Here Is What You Need to Know
Crude Oil Dips 3%; U.S. Bancorp Profit Tops Views
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling more than 100 points on Wednesday. The Dow traded up 0.04% to 37,813.77 while the NASDAQ fell 0.78% to 15,742.21.
Sector Update: Health Care Stocks Mixed Wednesday Afternoon
Health care stocks were mixed in Wednesday afternoon trading, with the NYSE Health Care Index fractionally higher and the Health Care Select Sector SPDR Fund (XLV) slightly lower. The iShares Biotechn
Vanda Pharmaceuticals Up Over 30%, on Pace for Largest Percent Increase Since November 2013 -- Data Talk
Vanda Pharmaceuticals Inc. (VNDA) is currently at $5.28, up $1.23 or 30.37% --Would be highest close since Aug. 30, 2023, when it closed at $5.35 --On pace for largest percent increase since Nov. 12
Sector Update: Health Care
Health care stocks were mixed Wednesday afternoon, with the NYSE Health Care Index fractionally higher and the Health Care Select Sector SPDR Fund (XLV) slightly lower. The iShares Biotechnology ETF (
Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of The Travelers Companies, Inc. (NYSE:TRV) fell sharply during Wednesday's session following first-quarter earnings. Travelers reported a mixed first quarter, with earnings lagging analyst' e
Neuropsychiatric-Focused Vanda Pharmaceuticals Rejects Future Pak's Takeover Bid Valued Up To $7.75/Share
On Wednesday, Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) confirmed that, since March 2024, it had received several unsolicited proposals from Future Pak LLC to acquire all of Vanda's outstanding shares.
Analysis
Price Target
No Data
